VIR – vir biotechnology, inc. (US:NASDAQ)
Stock Stats
News
Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results
Vir Biotechnology (NASDAQ:VIR) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Vir Biotechnology: The Low-Down On The Readouts Ahead [Seeking Alpha]
Vir Biotechnology (NASDAQ:VIR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Form 4 Vir Biotechnology, Inc. For: Feb 02 Filed by: SATO VICKI L
Form 144 Vir Biotechnology, Inc. Filed by: SVF Endurance (Cayman) Ltd
Form 8-K Vir Biotechnology, Inc. For: Jan 12
Form 4 Vir Biotechnology, Inc. For: Jan 02 Filed by: SATO VICKI L
Form 144 Vir Biotechnology, Inc. Filed by: SATO VICKI L
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.